Acorda Therapeutics $ACOR CFO, Michael Rogers has left the company, seemingly due to the demand of traveling from Boston. David Lawrence, meanwhile, has taken up the role of Principal Accounting Officer. He was serving as Chief of Business Operations. Andrew Hindman, who is serving as Chief Business Development Officer, will be having added responsibilities of Financial Planning and Analysis and Investor Relations. Mr. Rogers will now serve as a consultant through the end of the year to assist the transition.